LDL-c Level Variability and Trained Immunity
Conditions: Cholesterol Variability; Trained Immunity Intervention: Drug: Atorvastatin Sponsor: Wuhan Union Hospital, China Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2023 Category: Research Source Type: clinical trials
Description of the Effectiveness, Safety, Tolerability and Adherence to Amlodipine/Atorvastatin/Perindopril Single Pill Combination Treatment in Patients With Arterial Hypertension and Dyslipidemia in the Daily Clinical Practice. (TARGET)
Conditions: Arterial Hypertension; HTN Interventions: Drug: Amlodipine 5 mg + atorvastatin 10 mg + perindopril arginine 5 mg; Drug: Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 5 mg; Drug: Amlodipine 5 mg + atorvastatin 20 mg + perindopril arginine 10 mg Sponsor: Servier Russia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2023 Category: Research Source Type: clinical trials